| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $13.4M | +21.7% |
| SG&A Expense | $7.7M | -13.0% |
| Operating Income | -$21.1M | -6.3% |
| Pre-tax Income | -$21.0M | -8.1% |
| Income Tax | $0 | — |
| Net Income | -$21.0M | -8.1% |
| EPS (Basic) | -$0.62 | +15.1% |
| EPS (Diluted) | -$0.62 | +15.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.4M | +84.3% |
| Inventory | $103K | — |
| Current Assets | $4.7M | +69.1% |
| Total Assets | $5.8M | +78.4% |
| Total Liabilities | $3.2M | +99.8% |
| Stockholders' Equity | $2.6M | +57.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.0M | +3.3% |
| Capital Expenditures | $600K | +198.5% |
| Investing Cash Flow | -$600K | -198.5% |
| Financing Cash Flow | $16.6M | +1815.8% |
| Free Cash Flow | -$14.6M | +0.6% |